Friday, June 20, 2025
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Home 2021

Yearly Archives: 2021

Superbug News - CoronaVirus Watch List

Bill Gates Warns That a Next Pandemic Could Be 10 Times...

Editor / Curator -
Good Clinic, Biotech Stock Review
Biotech News

Mitesco (MITI) $0.45 to Open its First Medical Clinic.

Editor / Curator -
Psychedelic News

Why Isn’t Big Pharma Jumping Into Psychedelics (PsyTech).

Editor / Curator -
Citius, Biotech Stock Review
2020 Watch List

Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.

Editor / Curator -
Mitesco, Biotech Stock Review, roland rick perry
2020 Watch List

Short Squeeze Mania.

Editor / Curator -
Stem Cells

Video: Pacific Stem Cell

Editor / Curator -
ENDRA, Biotech Stock Review
Biotech News

Heads UP: ENDRA Life Science (NDRA) $1.50, up 40% Today.

Editor / Curator -
Internet Stock Review
Bitcoin

Is the Bitcoin Bubble More Fraud Than Frenzy?

Editor / Curator -
Biotech News

Make Hay While the Sun Shines. Up 6,400%.

Editor / Curator -
Internet Stock Review
Biotech News

And it’s Official. We Have Another Double. BioSig (BSGM) up 103%...

Editor / Curator -
1...171819Page 18 of 19

Latest article

Jeffrey Gundlach: Reckoning is Coming.

All News Editor / Curator -
Jeffrey Edward Gundlach is a businessman, fund manager, and philanthropist. He is the founder of DoubleLine Capital, an investment firm. On 11 November 2020, Gundlach remarked in an interview with...

Who’s the Next Eric Sprott?

All News Editor / Curator -
Eric Sprott, on Who is the Next Eric Sprott! To say Eric Sprott has left a legendary mark on the world of mining investment would...

Perpetua (PPTA) Raises $300 Million.

All News Editor / Curator -
Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.